By Jamie Martin
The Biotechnology Innovation Organization (BIO) has commended a recent update from the USDA's Animal and Plant Health Inspection Service (APHIS), which has expanded exemptions for genetically modified plants.
This change, under 7 CFR part 340, is seen as a significant move to align biotech regulations more closely with conventional breeding techniques, thereby facilitating easier market entry for new products.
This regulatory shift is expected to accelerate the development and commercialization of agricultural products that are both innovative and safe, with an emphasis on supporting sustainable agricultural practices.
The update is particularly beneficial not just for large biotech corporations but also for smaller enterprises and academic entities that contribute to agricultural research and development.
BIO has been instrumental in advocating for these regulatory adjustments, reflecting its commitment to fostering innovation within the U.S. agricultural sector.
The organization acknowledges the USDA's effort to incorporate nearly 6,500 public comments into their decision-making process, highlighting APHIS's dedication to transparency and stakeholder engagement.
As these new exemptions take effect, BIO anticipates they will reduce barriers for innovators and enhance the variety of crops that can be developed through biotechnology. This is expected to have positive implications for the U.S. economy and global food security.
Photo Credit: usda
Categories: National